by Simona Gilman | Sep 1, 2020 | Events
This year’s 2020 STAT Health Tech Summit will engage industry leaders, from giants like Apple and Google to upstarts emerging from stealth to discuss how breakthroughs in health and medicine are not just biological – they are technological. The two-day event will...
by Simona Gilman | Jul 21, 2020 | Press Releases
AI-driven in silico patients used to accurately identify types of immune responses in head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC). CAMBRIDGE, Mass.– [July 21, 2020] – GNS Healthcare (GNS), a leading AI and simulation company,...
by Simona Gilman | Jul 20, 2020 | News
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
by Simona Gilman | Jul 17, 2020 | News
Myeloma Research News covers GNS launch of Gemini. Read more here.
by Simona Gilman | Jul 8, 2020 | News
This is the first AI-based virtual patient for multiple myeloma, said Colin Hill, the Cambridge, Mass.-based company’s co-founder and chief executive. It is traditionally difficult to predict how specific drugs or combinations of drugs might help individual multiple...
